ENVOL is a French word that means to take off, and soar. The name symbolizes what we represent as a company, and how we envision our collaboration with our clients will help enable their technologies.

Envol Biomedical, established in 2019, is a growing preclinical contract research organization with a mission to be the leading nonhuman primate research facility in the country for the pharmaceutical industry.

The company has access to the largest population of NHP in the US, with lead times for new studies of 4-6 weeks. The laboratory has capabilities in multiple dose routes (including CNS, ophthalmic), specialized disease models and surgical collections. We have access to NHP resources that include cynomolgus macaque of numerous origins, marmosets, squirrel monkeys and African Green. The laboratory is supported by a clinical pathology and immunology core laboratory. Envol is AAALAC accredited, USDA and OLAW compliant.

Our business model is to provide our clients a high value research partner through speed, customer service and quality. We have a strong workforce that is managed by a leadership team with significant CRO and pharmaceutical industry experience. Envol aims to be GLP compliant in 2025.